Employees: 11 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2001-01-01 (25 years)Status: ActiveBusiness sector: Intermédiaires spécialisés dans le commerce d'autres produits spécifiquesLocation: NICE (06000), Alpes-Maritimes
PRESPHARM OUTRE-MER : revenue, balance sheet and financial ratios
PRESPHARM OUTRE-MER is a French company
founded 25 years ago,
specialized in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques.
Based in NICE (06000),
this company of category PME
shows in 2021 a revenue of 6.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PRESPHARM OUTRE-MER (SIREN 433943958)
Indicator
2024
2023
2021
2020
2019
2018
2016
2015
2014
Revenue
N/C
N/C
6 210 708 €
5 570 192 €
6 290 136 €
5 845 942 €
5 124 110 €
5 342 208 €
4 849 274 €
Net income
48 116 €
163 396 €
186 214 €
200 671 €
314 001 €
401 490 €
509 671 €
213 646 €
65 063 €
EBITDA
N/C
N/C
215 591 €
121 196 €
247 396 €
411 444 €
469 214 €
401 073 €
95 292 €
Net margin
N/C
N/C
3.0%
3.6%
5.0%
6.9%
9.9%
4.0%
1.3%
Revenue and income statement
In 2024, PRESPHARM OUTRE-MER generates positive net income of 48 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2024: 65 k€ -> 48 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
48 116 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.337%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
18.994%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2018
2019
2020
2021
2023
2024
Debt ratio
44.189
202.249
54.58
0.312
0.239
0.299
0.288
0.305
0.337
Financial autonomy
19.109
11.875
29.558
22.279
20.736
21.689
22.198
21.238
18.994
Repayment capacity
2.211
1.76
0.587
0.0
0.0
0.0
0.0
None
None
Cash flow / Revenue
1.341%
5.773%
10.238%
7.05%
4.031%
2.66%
3.056%
None%
None%
Sector positioning
Debt ratio
0.342024
2021
2023
2024
Q1: 0.0
Med: 5.8
Q3: 35.12
Good
In 2024, the debt ratio of PRESPHARM OUTRE-MER (0.34) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
18.99%2024
2021
2023
2024
Q1: 15.09%
Med: 44.33%
Q3: 67.75%
Average-6 pts over 3 years
In 2024, the financial autonomy of PRESPHARM OUTRE-MER (19.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.0 years2021
2021
Q1: 0.0 years
Med: 0.0 years
Q3: 1.38 years
Excellent
In 2021, the repayment capacity of PRESPHARM OUTRE-MER (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 120.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2014
2015
2016
2018
2019
2020
2021
2023
2024
Liquidity ratio
133.953
171.297
195.215
133.16
129.551
125.803
128.815
130.469
120.005
Interest coverage
7.77
0.831
0.085
0.0
0.0
0.0
0.0
None
None
Sector positioning
Liquidity ratio
120.02024
2021
2023
2024
Q1: 144.96
Med: 248.4
Q3: 435.6
Watch
In 2024, the liquidity ratio of PRESPHARM OUTRE-MER (120.00) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
0.0x2021
2021
Q1: 0.0x
Med: 0.0x
Q3: 1.28x
Average
In 2021, the interest coverage of PRESPHARM OUTRE-MER (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PRESPHARM OUTRE-MER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2018
2019
2020
2021
2023
2024
Operating WCR
317 240 €
591 703 €
287 924 €
889 577 €
1 250 731 €
1 437 165 €
1 073 086 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
37
67
44
55
61
72
63
0
0
Supplier payment term (days)
61
46
30
62
78
94
72
0
0
Positioning of PRESPHARM OUTRE-MER in its sector
Comparison with sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques
Valuation estimate
Based on 50 transactions of similar company sales
(all years),
the value of PRESPHARM OUTRE-MER is estimated at
77 194 €
(range 53 825€ - 264 961€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
50 tx
53k€77k€264k€
77 194 €Range: 53 825€ - 264 961€
NAF 5 all-time
Valuation method used
Net Income Multiple
48 116 €
×
1.6x
=77 194 €
Range: 53 825€ - 264 962€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 50 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Intermédiaires spécialisés dans le commerce d'autres produits spécifiques)
Compare PRESPHARM OUTRE-MER with other companies in the same sector:
Frequently asked questions about PRESPHARM OUTRE-MER
What is the revenue of PRESPHARM OUTRE-MER ?
The revenue of PRESPHARM OUTRE-MER in 2021 is 6.2 M€.
Is PRESPHARM OUTRE-MER profitable?
Yes, PRESPHARM OUTRE-MER generated a net profit of 48 k€ in 2024.
Where is the headquarters of PRESPHARM OUTRE-MER ?
The headquarters of PRESPHARM OUTRE-MER is located in NICE (06000), in the department Alpes-Maritimes.
Where to find the tax return of PRESPHARM OUTRE-MER ?
The tax return of PRESPHARM OUTRE-MER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PRESPHARM OUTRE-MER operate?
PRESPHARM OUTRE-MER operates in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques (NAF code 46.18Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart